Dr. Paul Alan Dreschnack, MD

Dr. Dreschnack practices at CityMD East 86th Urgent Care in New York, New York.

Dr. Dreschnack's NPI, 1073530804, was assigned on July 16, 2006. Dr. Dreschnack graduated from Ross University School of Medicine in 1983. Dr. Dreschnack holds New York license 170697.

Dr. Dreschnack's primary practice is CityMD East 86th Urgent Care, at 336 E 86th St, New York, NY 10028. The practice phone is (212) 390-8812.

Dr. Dreschnack's primary practice is CityMD East 86th Urgent Care in New York, New York. The medical group on file is CityMD. Dmand AI also links Dr. Dreschnack to 6 more medical groups and 1 physician office, each named with a free account. Dr. Dreschnack's employer is on file too: an urgent care center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dreschnack practices, 2 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Dreschnack's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dmand AI has Dr. Dreschnack's licenses on file in 6 states: New York, New Jersey, Louisiana, Connecticut, Florida and Pennsylvania.

CMS data shows 389 Medicare services from Dr. Dreschnack across 10 procedure codes in 2024, for 246 Medicare patients. Medicare paid $24,039 for them. Every service was in an office.

CMS counts 246 Medicare patients who saw Dr. Dreschnack in 2024. The largest group is 65 to 74, with 114 patients. 72% of them have high blood pressure, and 70% have high cholesterol. 16% are also on Medicaid. Their average risk score is 0.94, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dreschnack's median patient age at 33, with 71% women.

In 2024, Dr. Dreschnack wrote 504 Medicare Part D claims for 373 patients. 88% of them were for generic drugs. CMS names the drug for 333 of them, across 12 drugs with 11 or more claims each, at $3,409 in total drug cost. In 2019, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Dreschnack for performance year 2024, reported as part of a group. Dr. Dreschnack accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Dreschnack in 2023. Dr. Dreschnack's most frequent co-authors are Robert Johnson Allen, MD and Charles Louis Dupin, MD.

CMS Open Payments shows 2 general payments to Dr. Dreschnack from 2 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $27.

Dmand AI lists 1 award for Dr. Dreschnack, most recently Nobel Peace Prize Nomination in 2001.

Dr. Dreschnack graduated from Ross University School of Medicine in 1983.

Dr. Dreschnack is in network with 3 carriers, including Blue Cross and Blue Shield of Louisiana, CMS Medicare and NY State Medicaid. Medicaid plans come from the most carriers, 1. Check the plan with the practice before a visit.